TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+9.11%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.4B
AUM Growth
+$2.4B
(+12%)
Cap. Flow
+$85.1M
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
48.18%
Holding
111
New
19
Increased
30
Reduced
16
Closed
10
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$35.8M |
| 2 |
AbbVie
ABBV
|
$30.2M |
| 3 |
AGN
Allergan plc
AGN
|
$25M |
| 4 |
Baxter International
BAX
|
$21.9M |
| 5 |
Gilead Sciences
GILD
|
$19.5M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$59.8M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$48.5M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$28M |
| 4 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$22.4M |
| 5 |
Neurocrine Biosciences
NBIX
|
$19.8M |
Sector Composition
| 1 | Healthcare | 84.29% |
| 2 | Real Estate | 4.15% |
| 3 | Financials | 1.47% |
| 4 | Industrials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Perrigo
PRGO
$3.21B
| $21.6M | 0.86% |
130,652
+67,700
| +108% | +$11.2M |
|
27
Ventas
VTR
$30.7B
| $21.4M | 0.85% |
256,389
| – | – |
|
|
MDRX
28
DELISTED
Veradigm Inc. Common Stock
MDRX
| $21.3M | 0.84% |
1,778,200
+173,600
| +11% | +$2.08M |
|
29
Jazz Pharmaceuticals
JAZZ
$7.99B
| $20.9M | 0.83% |
120,741
-80,600
| -40% | -$13.9M |
|
|
RCPT
30
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $20.6M | 0.82% |
124,800
+104,400
| +512% | +$17.2M |
|
|
31
Neurocrine Biosciences
NBIX
$13.5B
| $19.9M | 0.79% |
501,150
-499,200
| -50% | -$19.8M |
|
32
iShares Biotechnology ETF
IBB
$5.68B
| $19.8M | 0.78% |
173,010
| – | – |
|
|
GEVA
33
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $19.4M | 0.77% |
198,689
-24,331
| -11% | -$2.37M |
|
34
Thermo Fisher Scientific
TMO
$183B
| $19M | 0.75% |
141,695
+20,700
| +17% | +$2.78M |
|
|
DOC
35
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $18.5M | 0.73% |
1,050,902
+92,900
| +10% | +$1.64M |
|
36
Medical Properties Trust
MPW
$2.66B
| $17M | 0.67% |
1,153,574
+174,800
| +18% | +$2.58M |
|
37
Omega Healthcare
OHI
$12.5B
| $16.8M | 0.66% |
413,116
+36,700
| +10% | +$1.49M |
|
|
IPXL
38
DELISTED
Impax Laboratories, Inc.
IPXL
| $16.2M | 0.64% |
344,683
| – | – |
|
39
McKesson
MCK
$85.9B
| $15.4M | 0.61% |
67,862
| – | – |
|
40
Sabra Healthcare REIT
SBRA
$4.56B
| $15.1M | 0.6% |
456,190
+48,300
| +12% | +$1.6M |
|
41
Karyopharm Therapeutics
KPTI
$61.4M
| $14.6M | 0.58% |
31,798
+22,614
| +246% | +$10.4M |
|
|
ALR
42
DELISTED
Alere Inc
ALR
| $14.6M | 0.58% |
297,901
| – | – |
|
43
Alnylam Pharmaceuticals
ALNY
$58.6B
| $13.6M | 0.54% |
130,195
+68,600
| +111% | +$7.16M |
|
|
WELL.PRI
44
DELISTED
Welltower Inc.
WELL.PRI
| $13.4M | 0.53% |
+200,000
| New | +$13.4M |
|
45
Heron Therapeutics
HRTX
$204M
| $12.7M | 0.5% |
873,940
| – | – |
|
46
Verastem
VSTM
$585M
| $12.7M | 0.5% |
104,152
+8,333
| +9% | +$1.02M |
|
47
Ironwood Pharmaceuticals
IRWD
$201M
| $12.3M | 0.49% |
917,052
| – | – |
|
48
Zimmer Biomet
ZBH
$20.8B
| $12M | 0.48% |
105,369
+23,175
| +28% | +$2.64M |
|
49
Stryker
SYK
$149B
| $11.4M | 0.45% |
123,940
+28,100
| +29% | +$2.59M |
|
50
HCA Healthcare
HCA
$95.4B
| $11.1M | 0.44% |
147,488
| – | – |
|